Related Experiment Video
Updated: Jan 12, 2026

11:11
Protocol for Repetitive Transcranial Magnetic Stimulation with Symptom Provocation to Treat Obsessive-compulsive Disorder
Published on: November 25, 2025
244
Invasive brain mapping identifies personalized therapeutic neuromodulation targets that suppress OCD network activity
A Moses Lee1,2, Audrey Kist3,4, John Alvarez3,4
1Weill Institute for Neurosciences, University of California, San Francisco, US. andrewmoses.lee@ucsf.edu.
Translational Psychiatry
|November 1, 2025
Summary
Personalized deep brain stimulation (DBS) using invasive brain mapping identified novel targets in the ventral capsule (VC) for treating refractory obsessive-compulsive disorder (OCD), leading to rapid symptom improvement.
Area of Science:
- Neuroscience
- Neurosurgery
- Psychiatry
Background:
- Deep brain stimulation (DBS) is used for severe, refractory obsessive-compulsive disorder (OCD).
- Outcomes vary significantly depending on the anatomical targets used.
- Limitations necessitate novel approaches for personalized treatment.
Purpose of the Study:
- To develop and validate an invasive brain mapping paradigm for personalized neuromodulation in refractory OCD.
- To identify specific targets within the cortico-striato-thalamo-cortical circuit for optimal symptom reduction.
- To characterize the downstream circuit effects of personalized stimulation.
Main Methods:
- Developed an invasive brain mapping paradigm involving electrode implantation across the OCD circuit.
- Performed extensive stimulation mapping over multiple days to identify personalized therapeutic targets.
- Characterized downstream circuit effects, including suppression of high-frequency activity in connected cortical regions.
Main Results:
- Identified two specific targets within the right ventral capsule (VC) that acutely reduced OCD symptoms.
- Prolonged VC stimulation suppressed high-frequency activity in the orbitofrontal and cingulate cortex.
- These connected cortical regions were identified as key nodes encoding OCD symptom severity.
Conclusions:
- This study provides the first proof-of-concept for invasive brain mapping to guide personalized neuromodulation in refractory OCD.
- A novel personalized, multi-site neuromodulation approach using VC targets demonstrated a rapid therapeutic response.
- This approach offers a promising strategy for optimizing DBS outcomes in severe, treatment-resistant OCD.

